Two Years of Adjuvant Tamoxifen Provides a Survival Benefit Compared With No Systemic Treatment in Premenopausal Patients With Primary Breast Cancer: Long-Term Follow-Up (> 25 years) of the Phase III SBII:2pre Trial
| Image |  |
|---|---|
| Description | scientific article published on 9 May 2016 |
| Author/s |
author: Olle Stål Pär-Ola Bendahl |
| Publication date | May 9, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |